048410.KQ
Hyundai Bioscience Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 6,050.00
−0.49%Leverage
- Debt / equity
- 0.22x
- Net debt / equity
- 0.06x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -1.28x
- Net debt / EBITDA
- -0.32x
Liquidity & coverage
- Current ratio
- 2.36x
- Quick ratio
- 2.32x
- Cash ratio
- 2.26x
- Interest coverage
- -11.31x
- EBITDA / interest
- -10.47x
- Working capital
- KRW 25.3B
Cash & dividend
- FCF / debt
- -0.78x
- Cash flow / debt
- -0.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026